Investor Releases

Date	Title	View
25 July, 2018	ICON Reports Second Quarter 2018 Results
25 July, 2018	ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
27 June, 2018	ICON Is Collaborating with Practice Fusion, Inc. to Advance Health Research
11 June, 2018	ICON Enhances Endpoint Adjudication Services Using AG Mednet Advanced Technology
21 May, 2018	ICON launches FIRECREST Financial Disclosure to Reduce Administrative Costs and Increase Regulatory Compliance
16 May, 2018	ICON Named by Forbes as One of the Best Employers in America
09 May, 2018	ICON Sponsors Industry-Wide Clinical Trials Survey to Support Transforming Trials Initiative
02 May, 2018	ICON Reports First Quarter 2018 Results
17 April, 2018	ICON Announces Agreement with Intel Allowing Integration of the Intel® Pharma Analytics Platform for Clinical Trials
03 April, 2018	ICON Announces Launch of Government and Public Health Solutions to Support Global Public Health
15 February, 2018	ICON Reports Fourth Quarter and Full Year 2017 Results
09 January, 2018	ICON Issues Financial Guidance for Full Year 2018
09 January, 2018	ICON Appoints Dr. James Cummings as President of ClinicalRM
30 November, 2017	ICON Wins Best Contract Research Organisation at the Annual Scrip Awards 2017
21 November, 2017	ICON Launches FIRECREST Pre-Screen to Improve the Speed and Accuracy of Identifying Eligible Patients for Screening
17 November, 2017	ICON Announces Appointment of Ms. Joan Garahy to Board of Directors
16 November, 2017	MediMedia Managed Markets, an ICON Company, Wins Two Gold Industry Awards for Data Analytics and Healthcare Communications
07 November, 2017	ICON Contributes to Major European Research Study That Aims to Improve Treatment for Traumatic Brain Injury
06 November, 2017	ICON Reveals Voice-Assistant Applications for Clinical Trials at ISPOR Annual European Congress
26 October, 2017	ICON Reports Third Quarter 2017 Results

Investor Releases

Investor Releases

Search Investor